Results: 5334

For: Publication types

All eyes on the ward: the use and impact of surveillance in inpatient mental health settings

Featured

Nima Hunt summarises a new systematic review published today on the use and impact of surveillance-based technology initiatives in inpatient and acute mental health settings. The review suggests that surveillance technologies should not be used in mental health settings until further research supports their use.

[read the full story...]

Recovery under close observation – three decades on

View up and enclosed tunnel with a slow sign painted on the ground.

Recovery has been a driver for policy and practice for thirty years, but this observational study leaves questions about how embedded it really is.

[read the full story...]

Can behavioural programmes reduce partner abuse by people with mental illness or substance use problems? #16DaysOfActivism2024

Featured

Today is the beginning of #16DaysOfActivism2024 for No Violence against Women and Children. To mark the occasion we have a blog from Vishal Bhavsar exploring the effectiveness of interventions for perpetrators of intimate partner violence.

[read the full story...]

Suicide prevention: expanding the narrative to preventing the crisis, not just treating the crisis

silhouette of woman holding megaphone

Something a bit different today, as Kirsten Lawson summarises the recent Lancet Public Health series on suicide prevention, which looks at public health interventions, addressing the risk factors and determinants of suicide, and the transmissibility of suicide.

[read the full story...]

How has the hostile environment policy worsened the mental health of people from minoritised ethnic groups?

LONDON, UK -20 MAY 2017- Sign for the UK Border at London Heathrow International Airport (LHR).  The UK and European Union  countries have separate passport control and immigration lanes.

Briony Tatem considers a study in The Lancet, which explores the effect of immigration policy reform on mental health in people from minoritised ethnic groups in England, using longitudinal data from the UK Household Longitudinal Study cohort.

[read the full story...]

KarXT: an innovative and promising treatment for schizophrenia

Hands holding paper head, human brain with flowers, self care and mental health concept, positive thinking, creative mind

Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.

[read the full story...]

Post-traumatic growth in refugees and asylum seekers: reclaiming life through shared stories and community

jeremy-bishop-vGjGvtSfys4-unsplash

Jeremy Lyons summarises an updated systematic review on post-traumatic growth among refugee and asylum-seeking populations, which provides insights into coping mechanisms that help refugees grow after trauma, such as religion, employment and psychological support.

[read the full story...]

Psychotropic medication during pregnancy: new umbrella review finds no convincing evidence of adverse health outcomes for the baby

Featured

Flo Martin summarises a recent umbrella review which finds that we still have limited knowledge about the safety of psychotropic drug use in pregnancy.

[read the full story...]

Alcohol and interpersonal violence: new review estimates how many adults experience emotional violence from others’ drinking

priscilla-du-preez-NQTphr4Pr60-unsplash

Nora de Bode looks at the international prevalence of interpersonal violence due to others’ alcohol consumption. This new review finds that in 2019, around 1 in 4 adults in Central Europe, Eastern Europe, and Central Asia, and 1 in 6 adults in high income regions, experienced emotional violence from others’ drinking.

[read the full story...]

Antidepressant discontinuation symptoms: what do the data really tell us?

julia-zolotova-5ZofAm1f27E-unsplash

Gemma Lewis and Glyn Lewis summarise a robust systematic review and meta-analysis investigating the incidence of symptoms when discontinuing or withdrawing from antidepressants. The data suggest that 8-14% of patients will experience antidepressant discontinuation symptoms, and for around 2% these symptoms will be severe.

[read the full story...]